Moreover, a meta-analysis study demonstrates that administration of GLP-1 receptor agonists in diabetes patients exhibits slightly better effects on blood glucose control compared with insulin therapy (Abd El Aziz et al., 2016). Here, GLP1R is linked to diabetes mellitus.